Unknown

Dataset Information

0

The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-?B activation and induces apoptosis in chronic lymphocytic leukemia B cells.


ABSTRACT: Stromal-mediated signaling enhances NF-?B pathway activity in chronic lymphocytic leukemia (CLL) B cells, leading to cell survival and chemoresistance. Ubiquitination of I?B? may partially account for constitutive activation of NF-?B. MLN4924 is an investigational agent that inhibits the Nedd8-activating enzyme, thereby neutralizing Cullin-RING ubiquitin ligases and preventing degradation of their substrates.We conducted a preclinical assessment of MLN4924 in CLL. Primary CLL cells were cocultured in vitro with CD40L-expressing stroma to mimic the prosurvival conditions present in lymphoid tissue. The effect of MLN4924 on CLL cell apoptosis, NF-?B pathway activity, Bcl-2 family members, and cell cycle was assessed by flow cytometry, Western blotting, PCR, and immunocytochemistry.CD40L-expressing stroma protected CLL cells from spontaneous apoptosis and induced resistance to multiple drugs, accompanied by NF-?B activation and Bim repression. Treatment with MLN4924 induced CLL cell apoptosis and circumvented stroma-mediated resistance. This was accompanied by accumulation of phospho-I?B?, decreased nuclear translocation of p65 and p52 leading to inhibition of both the canonical and noncanonical NF-?B pathways, and reduced transcription of their target genes, notably chemokines. MLN4924 promoted induction of Bim and Noxa in the CLL cells leading to rebalancing of Bcl-2 family members toward the proapoptotic BH3-only proteins. siRNA-mediated knockdown of Bim or Noxa decreased sensitivity to MLN4924. MLN4924 enhanced the antitumor activity of the inhibitors of B-cell receptor (BCR)-associated kinases.MLN4924 disrupts NF-?B activation and induces Bim expression in CLL cells, thereby preventing stroma-mediated resistance. Our data provide rationale for further evaluation of MLN4924 in CLL.

SUBMITTER: Godbersen JC 

PROVIDER: S-EPMC3960291 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells.

Godbersen J Claire JC   Humphries Leigh Ann LA   Danilova Olga V OV   Kebbekus Peter E PE   Brown Jennifer R JR   Eastman Alan A   Danilov Alexey V AV  

Clinical cancer research : an official journal of the American Association for Cancer Research 20140301 6


<h4>Background</h4>Stromal-mediated signaling enhances NF-κB pathway activity in chronic lymphocytic leukemia (CLL) B cells, leading to cell survival and chemoresistance. Ubiquitination of IκBα may partially account for constitutive activation of NF-κB. MLN4924 is an investigational agent that inhibits the Nedd8-activating enzyme, thereby neutralizing Cullin-RING ubiquitin ligases and preventing degradation of their substrates.<h4>Experimental design</h4>We conducted a preclinical assessment of  ...[more]

Similar Datasets

| S-EPMC4120840 | biostudies-literature
| S-EPMC3251739 | biostudies-literature
| S-EPMC4297545 | biostudies-literature
| S-EPMC5296256 | biostudies-literature
| S-EPMC3823062 | biostudies-literature
| S-EPMC3226404 | biostudies-literature
| S-EPMC3972249 | biostudies-literature
| S-EPMC5029665 | biostudies-literature
| S-EPMC6738521 | biostudies-literature
| S-EPMC6690881 | biostudies-literature